BPA Call VA24615A0004-VA24615J0164

This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, doing business as Quest Diagnostics, for a Hepatitis C Prevalence Study. The $1,992,000.00 contract is to conduct a cross-sectional, multi-state assessment of viral hepatitis C prevalence through commercial laboratory testing of stored serum specimens, with a period of performance from September 2023 to September 2024. Quest Diagnostics has provided...

Qoolabs Inc. has been awarded a $400,000 firm fixed price contract by the Department of Health and Human Services National Institutes of Health National Cancer Institute to develop an at-home rapid test for hepatitis C virus detection. This contract was awarded under the Small Business Innovation Research Program Phase I action, which is set aside for small businesses. Work will be conducted by Qoolabs in San Diego, California through September 2023. The contract responds to a 2020...

This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for Hepatitis C genotyping and quantitative PCR test kits and reagents for the Abbott M2000 SP/RT diagnostic systems. The contract was awarded on April 1, 2017 as a Blanket Purchase Agreement (BPA) call under the GSA Federal Supply Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits, with a potential value of...

This is a firm fixed-price BPA call awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation to provide the COBAS AMPLIPREP/TAQMAN HCV TEST V2.0, a laboratory diagnostic product for the detection of hepatitis C virus (HCV). The contract has a ceiling value of $96,922.23 and an ultimate completion date of March 12, 2021. Roche Diagnostics is a large manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and...

This federal contract award to Center For Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings, is for the provision of medical laboratory testing services to detect the antigens and antibodies of Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antibody (HBsAb), Hepatitis B Surface Antigen (HBsAg), and Hepatitis C Virus (anti-HCV). The award, issued by the U.S. Department of Defense's Readiness Center, has a ceiling value of $958,699.10 and a period of...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,162,000.00 firm fixed-price definitive contract to Quest Diagnostics Incorporated for "Monitoring National Viral Hepatitis Epidemic Data". The contract, which does not have a set-aside designation, was awarded on September 29, 2017 with a completion date of September 28, 2022. Quest Diagnostics, a for-profit provider of diagnostic information services, has received multiple federal...

This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide Hepatitis C Virus (HCV) genotyping services to the Department of Veterans Affairs (VA). The award, with a ceiling value of $89,610.54, was issued on October 1, 2017 and has an ultimate completion date of September 30, 2018. The contract is a Blanket Purchase Agreement (BPA) call, with a Firm Fixed Price pricing type, under the General Services Administration (GSA) Schedule contract for In...

The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Vela Diagnostics USA Inc., a for-profit organization, to provide viral next-generation sequencing (NGS) testing for genotyping and resistance of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) at a cost of $148,104.85. The contract, which was not set aside, has a completion date of September 30, 2022. Vela Diagnostics USA Inc. has previously provided federal agencies,...

This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs to Siemens Healthcare Diagnostics Inc. for the provision of hepatitis C virus (HCV) genotype test kits and associated supplies. The contract has a ceiling value of $90,077.90 and a period of performance through September 29, 2017. It is not set aside for any particular business type. Siemens Healthcare Diagnostics Inc. is a subsidiary of Siemens Aktiengesellschaft, a global technology company, and provides in...

The Department of the Army Medical Command awarded a $40,000 firm fixed price call against its Blanket Purchase Agreement to Gen-Probe Incorporated for APTIMA HCV RNA QUALITATIVE ASSAY diagnostic test kits. The contract has a period of performance through August 30, 2021 for delivery to a location in Marlborough, Massachusetts. Gen-Probe Sales & Service, Inc. will perform as the prime contractor, with no subcontractors or set aside designation indicated. This diagnostic test supports the...